Photo of Steven L. Chang, MD

Steven L. Chang, MD

Brigham And Women's Hospital

Brigham And Women's Hospital
Phone: (617) 525-3117
Fax: (617) 566-3475


SLCHANG@partners.org

Photo of Steven L. Chang, MD

Brigham And Women's Hospital
Phone: (617) 525-3117
Fax: (617) 566-3475


SLCHANG@partners.org

Visualize Collaborations
Learn how these members are similar
Similar Members

DF/HCC members that share similar concepts* with Steven L. Chang, MD but have yet to coauthor a publication with this researcher.

* Concepts are MeSH terms, automatically derived from member publications

Similar Members

Steven L. Chang, MD

Brigham And Women's Hospital

EDUCATIONAL TITLES

  • Associate Professor, Surgery, Harvard Medical School
  • Associate Surgeon, Surgery, Brigham And Women's Hospital

DF/HCC PROGRAM AFFILIATION

Research Abstract

As a fellowship trained Urologic Oncologist, I have expertise in the evaluation and management of patients with urologic malignancies. I also have a Master of Science in Health Services Research, which has allowed me to apply principles of economic evaluation and decision analysis to clinical problems in urology. The overarching goal of the my research is to develop clinical recommendations that will improve the care of patients with urologic malignancies while reducing over the overall burden of these diseases on the United States health care system.

Publications from Harvard Catalyst Profiles

Powered by Harvard Catalyst
  • Nolazco JI, Chang SL. Role of Surgery in Metastatic Renal Cell Carcinoma. Hematol Oncol Clin North Am 2023. PubMed
  • Labban M, Frego N, Qian ZJ, Koelker M, Reese S, Aliaj A, Cole AP, Chang SL, Preston MA, Kibel AS, Trinh QD. Institutional trends and safety profile of same-day discharge for robot-assisted laparoscopic radical prostatectomy: A retrospective analysis. Urol Oncol 2023. PubMed
  • Leow JJ, Ray S, Dason S, Singer EA, Chang SL. The Promise of Neoadjuvant and Adjuvant Therapies for Renal Cancer. Urol Clin North Am 2023; 50:285-303. PubMed
  • Nolazco JI, Mucci LA, Sosnowski R, Przewoźniak K, Chang SL, De Nunzio C. Relationship between cigarette use and prostate cancer risk: what do we know and what should we do? Prostate Cancer Prostatic Dis 2023. PubMed
  • Tully KH, Berg S, Paciotti M, Janisch F, Reese SW, Noldus J, Shariat SF, Choueiri T, Müller G, McGregor B, Chang SL, Trinh QD, Mossanen M. The Natural History of Renal-Cell Carcinoma with Sarcomatoid Differentiation, a Stage-by-Stage Analysis. Clin Genitourin Cancer 2023; 21:63-68. PubMed
  • Chai JL, Alencar RO, Hirsch MS, Bhagavatula S, Bay CP, Siegmund S, Chang SL, Silverman SG. Reliability and Management Outcomes Following a Percutaneous Biopsy Diagnosis of Oncocytoma: A 15-year Retrospective Analysis. Radiology 2023. PubMed
  • Koelker M, Krimphove M, Alkhatib K, Nabi J, Kuo LE, Lipsitz SR, Choueiri TK, Chang SL, Doherty GM, Kibel AS, Trinh QD, Cole AP. Understanding Hospital-Level Patterns of Nonoperative Management for Low-risk Thyroid and Kidney Cancer. JAMA Netw Open 2022; 5:e2242210. PubMed
  • Tan WS, Koelker M, Campain N, Cole AP, Labban M, Mossanen M, Barod R, Kibel AS, Chang SL, Bex A, Trinh QD. Comparison of Long-term Outcomes for Young and Healthy Patients with cT1a and cT3a Renal Cell Carcinoma Treated with Partial Nephrectomy. Eur Urol Focus 2022. PubMed
  • Giganti F, Cole AP, Fennessy FM, Clinton T, Moreira PLDF, Bernardes MC, Westin CF, Krishnaswamy D, Fedorov A, Wollin DA, Langbein B, Frego N, Labban M, Badaoui JS, Chang SL, Briggs LG, Tokuda J, Ambrosi A, Kirkham A, Emberton M, Kasivisvanathan V, Moore CM, Allen C, Tempany CM. Promoting the use of the PI-QUAL score for prostate MRI quality: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship. Eur Radiol 2022. PubMed
  • Graff RE, Wilson KM, Sanchez A, Chang SL, McDermott DF, Choueiri TK, Cho E, Signoretti S, Giovannucci EL, Preston MA. Obesity in Relation to Renal Cell Carcinoma Incidence and Survival in Three Prospective Studies. Eur Urol 2022. PubMed
  • Patel HV, Sterling JA, Srivastava A, Ghodoussipour SB, Jang TL, Grandhi MS, August DA, Rahimi SA, Chung BI, Chang SL, Singer EA. The Impact of Venous Thromboembolism on Mortality and Morbidity During Nephrectomy for Renal Mass. Urology 2022. PubMed
  • Carvalho FLF, Wang Y, Dall CP, Nayan M, Chou WH, McGregor B, Stopfkuchen-Evans MF, Stamatakis L, Preston MA, Kibel AS, Chang SL, Mossanen M. Preoperative anemia is associated with increased radical cystectomy complications. Urol Oncol 2022. PubMed
  • Bakouny Z, Sadagopan A, Ravi P, Metaferia NY, Li J, AbuHammad S, Tang S, Denize T, Garner ER, Gao X, Braun DA, Hirsch L, Steinharter JA, Bouchard G, Walton E, West D, Labaki C, Dudani S, Gan CL, Sethunath V, Carvalho FLF, Imamovic A, Ricker C, Vokes NI, Nyman J, Berchuck JE, Park J, Hirsch MS, Haq R, Mary Lee GS, McGregor BA, Chang SL, Feldman AS, Wu CJ, McDermott DF, Heng DYC, Signoretti S, Van Allen EM, Choueiri TK, Viswanathan SR. Integrative clinical and molecular characterization of translocation renal cell carcinoma. Cell Rep 2022; 38:110190. PubMed
  • Yu A, Wang Y, Mossanen M, Preston M, Carvalho FL, Chung BI, Chang SL. Robotic-assisted radical cystectomy is associated with lower perioperative mortality in octogenarians. Urol Oncol 2021. PubMed
  • Chou WH, McGregor B, Schmidt A, Carvalho FLF, Hirsch MS, Chang SL, Kibel A, Mossanen M. Cyclophosphamide-associated bladder cancers and considerations for survivorship care: A systematic review. Urol Oncol 2021. PubMed
  • Goldberg IP, Chang SL, Kundu SD, Chung BI, Singer EA. Impact of inflammatory bowel disease on radical prostatectomy outcomes and costs of care. Prostate Int 2021; 9:66-71. PubMed
  • Bi K, He MX, Bakouny Z, Kanodia A, Napolitano S, Wu J, Grimaldi G, Braun DA, Cuoco MS, Mayorga A, DelloStritto L, Bouchard G, Steinharter J, Tewari AK, Vokes NI, Shannon E, Sun M, Park J, Chang SL, McGregor BA, Haq R, Denize T, Signoretti S, Guerriero JL, Vigneau S, Rozenblatt-Rosen O, Rotem A, Regev A, Choueiri TK, Van Allen EM. Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma. Cancer Cell 2021; 39:649-661.e5. PubMed
  • Braun DA, Street K, Burke KP, Cookmeyer DL, Denize T, Pedersen CB, Gohil SH, Schindler N, Pomerance L, Hirsch L, Bakouny Z, Hou Y, Forman J, Huang T, Li S, Cui A, Keskin DB, Steinharter J, Bouchard G, Sun M, Pimenta EM, Xu W, Mahoney KM, McGregor BA, Hirsch MS, Chang SL, Livak KJ, McDermott DF, Shukla SA, Olsen LR, Signoretti S, Sharpe AH, Irizarry RA, Choueiri TK, Wu CJ. Progressive immune dysfunction with advancing disease stage in renal cell carcinoma. Cancer Cell 2021; 39:632-648.e8. PubMed
  • McKay RR, Xie W, Ye H, Fennessy FM, Zhang Z, Lis R, Calagua C, Rathkopf D, Laudone VP, Bubley GJ, Einstein DJ, Chang PK, Wagner AA, Parsons JK, Preston MA, Kilbridge K, Chang SL, Choudhury AD, Pomerantz MM, Trinh QD, Kibel AS, Taplin ME. Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer. J Urol 2021. PubMed
  • Tan WS, Marchese M, Paciotti M, Nguyen DD, Cone EB, Mossanen M, Webster JJ, Barod R, Bex A, Kibel AS, Chang SL, Trinh QD. Delay in surgery for cT1b-2 kidney cancer beyond 90 days is associated with poorer survival: Implications for prioritization during the COVID-19 pandemic. Minerva Urol Nephrol 2021. PubMed
  • Krimphove MJ, Reese SW, Chen X, Marchese M, Pucheril D, Cone E, Chou W, Tully KH, Kibel AS, Urman RD, Chang SL, Kluth LA, Dasgupta P, Trinh QD. Recovery from minimally invasive vs. open surgery in kidney cancer patients: Opioid use and workplace absenteeism. Investig Clin Urol 2021; 62:56-64. PubMed
  • Bakouny Z, Braun DA, Shukla SA, Pan W, Gao X, Hou Y, Flaifel A, Tang S, Bosma-Moody A, He MX, Vokes N, Nyman J, Xie W, Nassar AH, Abou Alaiwi S, Flippot R, Bouchard G, Steinharter JA, Nuzzo PV, Ficial M, Sant'Angelo M, Forman J, Berchuck JE, Dudani S, Bi K, Park J, Camp S, Sticco-Ivins M, Hirsch L, Baca SC, Wind-Rotolo M, Ross-Macdonald P, Sun M, Lee GM, Chang SL, Wei XX, McGregor BA, Harshman LC, Genovese G, Ellis L, Pomerantz M, Hirsch MS, Freedman ML, Atkins MB, Wu CJ, Ho TH, Linehan WM, McDermott DF, Heng DYC, Viswanathan SR, Signoretti S, Van Allen EM, Choueiri TK. Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma. Nat Commun 2021; 12:808. PubMed
  • Haeuser L, Marchese M, Schrag D, Trinh QD, Chang SL, Kibel AS, Gore JL, Noldus J, Mossanen M. The impact of smoking on radical cystectomy complications increases in elderly patients. Cancer 2020. PubMed
  • Huynh MJ, Wang Y, Joshi M, Krasnow R, Yu AX, Mossanen M, Chung BI, Chang SL. Patient factors predict complications after partial nephrectomy: validation and calibration of the Preoperative Risk Evaluation for Partial Nephrectomy (PREP) score. BJU Int 2020. PubMed
  • Ozambela M, Wang Y, Leow JJ, Silverman SG, Chung BI, Chang SL. Contemporary trends in percutaneous renal mass biopsy utilization in the United States. Urol Oncol 2020. PubMed
  • Bhagavatula SK, Tuncali K, Shyn PB, Levesque VM, Chang SL, Silverman SG. Percutaneous CT- and MRI-guided Cryoablation of cT1 Renal Cell Carcinoma: Intermediate- to Long-term Outcomes in 307 Patients. Radiology 2020; 296:687-695. PubMed
  • Leow JJ, Chong YL, Chang SL, Valderrama BP, Powles T, Bellmunt J. Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy. Eur Urol 2020. PubMed
  • Huynh MJ, Wang Y, Chang SL, Tully KH, Chung BI, Wright JL, Mossanen M. The cost of obesity in radical cystectomy. Urol Oncol 2020. PubMed
  • Nuzzo PV, Berchuck JE, Korthauer K, Spisak S, Nassar AH, Abou Alaiwi S, Chakravarthy A, Shen SY, Bakouny Z, Boccardo F, Steinharter J, Bouchard G, Curran CR, Pan W, Baca SC, Seo JH, Lee GM, Michaelson MD, Chang SL, Waikar SS, Sonpavde G, Irizarry RA, Pomerantz M, De Carvalho DD, Choueiri TK, Freedman ML. Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes. Nat Med 2020. PubMed
  • Tan WS, Wang Y, Trinh QD, Preston MA, Kelly JD, Hrouda D, Kibel AS, Krasnow RE, Liu JJ, Chung BI, Chang SL, Mossanen M. Delayed blood transfusion is associated with mortality following radical cystectomy. Scand J Urol 2020. PubMed
  • Huang JT, Cole AP, Mossanen M, Preston MA, Wang Y, Kibel AS, Chung BI, Huang WJ, Chang SL. Alvimopan Is Associated With a Reduction in Length of Stay and Hospital Costs for Patients Undergoing Radical Cystectomy. Urology 2020; 140:115-121. PubMed
  • Mossanen M, Chang SL. Beyond bladder cancer surveillance: building a survivorship clinic. BJU Int 2020; 125:2-3. PubMed
  • Tully KH, Krimphove MJ, Reese SW, Kibel AS, Noldus J, Krasnow RE, Trinh QD, Sonpavde GP, Chang SL, Mossanen M. Trends in Adherence to Thromboprophylaxis Guideline in Patients Undergoing Radical Cystectomy. Urology 2020; 135:44-49. PubMed
  • McClintock TR, Gondi S, Wang Y, Friedlander DF, Cole AP, Sun M, Melnitchouk N, Chang SL, Haider AH, Weissman JS, Trinh QD. Association of Affordable Care Act-related Medicaid expansion with variation in utilization of surgical services. Am J Surg 2019. PubMed
  • Tan WS, Trinh QD, Hayn MH, Marchese M, Lipsitz SR, Nabi J, Kilbridge KL, Vale JA, Khoubehi B, Kibel AS, Sun M, Chang SL, Sammon JD. Delayed nephrectomy has comparable long-term overall survival to immediate nephrectomy for cT1a renal cell carcinoma: A population-based analysis. Urol Oncol 2019. PubMed
  • Bossé D, Lin X, Simantov R, Lalani AA, Derweesh I, Chang SL, Choueiri TK, McKay RR. Response of Primary Renal Cell Carcinoma to Systemic Therapy. Eur Urol 2019; 76:852-860. PubMed
  • Tully KH, Krimphove Md MJ, Huynh MJ, Marchese M, Kibel AS, Noldus J, Kluth LA, McGregor B, Chang SL, Trinh QD, Mossanen M. Differences in survival and impact of adjuvant chemotherapy in patients with variant histology of tumors of the renal pelvis. World J Urol 2019. PubMed
  • McClintock TR, Shah MA, Chang SL, Haleblian GE. Time-Driven Activity-Based Costing in Urologic Surgery Cycles of Care. Value Health 2019; 22:768-771. PubMed
  • McClintock TR, Wang Y, Shah MA, Mossanen M, Chung BI, Chang SL. Hospital Charges for Urologic Surgery Episodes of Care Are Rising Despite Declining Costs. Mayo Clin. Proc. 2019; 94:995-1002. PubMed
  • McKay RR, Ye H, Xie W, Lis R, Calagua C, Zhang Z, Trinh QD, Chang SL, Harshman LC, Ross AE, Pienta KJ, Lin DW, Ellis WJ, Montgomery B, Chang P, Wagner AA, Bubley GJ, Kibel AS, Taplin ME. Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone. J Clin Oncol 2019; 37:923-931. PubMed
  • Psutka SP, Chang SL, Cahn D, Uzzo RG, McGregor BA. Reassessing the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in 2019. Am Soc Clin Oncol Educ Book 2019; 39:276-283. PubMed
  • Gupta S, Cole AP, Marchese M, Wang Y, Speed JM, Fletcher SA, Nabi J, Berg S, Lipsitz SR, Choueiri TK, Chang SL, Kibel AS, Uhlig A, Trinh QD. Use of Preventive Health Services Among Cancer Survivors in the U.S. Am J Prev Med 2018; 55:830-838. PubMed
  • Mossanen M, Krasnow RE, Zlatev DV, Tan WS, Preston MA, Trinh QD, Kibel AS, Sonpavde G, Schrag D, Chung BI, Chang SL. Examining the relationship between complications and perioperative mortality following radical cystectomy: A population-based analysis. BJU Int 2018. PubMed
  • Mossanen M, Wang Y, Szymaniak J, Tan WS, Huynh MJ, Preston MA, Trinh QD, Sonpavde G, Kibel AS, Chang SL. Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categories. World J Urol 2018. PubMed
  • Li K, Brandes ER, Chang SL, Leow JJ, Chung BI, Wang Y, Eswara JR. Trends in penile prosthesis implantation and analysis of predictive factors for removal. World J Urol 2018. PubMed
  • Krasnow RE, Rodríguez D, Nagle RT, Mossanen M, Kibel AS, Chang SL. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies. Urol Oncol 2018. PubMed
  • Chiang HA, Cheng PJ, Speed JM, Steinberg J, Najjar PA, Steele GS, Trinh QD, Eswara JR, Chang SL, Kibel AS, Stopfkuchen-Evans MF, Preston MA. Implementation of a Perioperative Venous Thromboembolism Prophylaxis Program for Patients Undergoing Radical Cystectomy on an Enhanced Recovery After Surgery Protocol. Eur Urol Focus 2018. PubMed
  • Berg S, Cole AP, Fletcher SA, Pucheril D, Nabi J, Lipsitz SR, Chang SL, Sun M, Noldus J, Harshman LC, Choueiri TK, Trinh QD. Investigating the effect of treatment at high-volume hospitals on overall survival following cytoreductive nephrectomy. Urol Oncol 2018; 36:400.e15-400.e22. PubMed
  • Ha A, Krasnow RE, Mossanen M, Nagle R, Hshieh TT, Rudolph JL, Chang SL. A contemporary population-based analysis of the incidence, cost, and outcomes of postoperative delirium following major urologic cancer surgeries. Urol Oncol 2018; 36:341.e15-341.e22. PubMed
  • Sun M, Meyer CP, Karam JA, de Velasco G, Chang SL, Pal SK, Trinh QD, Choueiri TK. Predictors, utilization patterns, and overall survival of patients undergoing metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy. Eur J Surg Oncol 2018. PubMed
  • McClintock TR, Wang Y, Cole AP, Chung BI, Kibel AS, Chang SL, Trinh QD. Contemporary trends in the utilisation of radical prostatectomy. BJU Int 2018. PubMed
  • Mossanen M, Chang SL, Kimm S, Sonpavde GP, Kibel AS. Current Staging Strategies for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma. Urol Clin North Am 2018; 45:143-154. PubMed
  • Wang Y, Mossanen M, Chang SL. Cost and cost-effectiveness studies in urologic oncology using large administrative databases. Urol Oncol 2018. PubMed
  • Jeong IG, Khandwala YS, Kim JH, Han DH, Li S, Wang Y, Chang SL, Chung BI. Association of Robotic-Assisted vs Laparoscopic Radical Nephrectomy With Perioperative Outcomes and Health Care Costs, 2003 to 2015. JAMA 2017; 318:1561-1568. PubMed
  • Mossanen M, Krasnow RE, Lipsitz SR, Preston MA, Kibel AS, Ha A, Gore JL, Smith AB, Leow JJ, Trinh QD, Chang SL. Associations of specific postoperative complications with costs after radical cystectomy. BJU Int 2017. PubMed
  • Faiena I, Tabakin A, Leow J, Patel N, Modi PK, Salmasi AH, Chung BI, Chang SL, Singer EA. Adrenalectomy for benign and malignant disease: utilization and outcomes by surgeon specialty and surgical approach from 2003-2013. Can J Urol 2017; 24:8990-8997. PubMed
  • Khandwala YS, Jeong IG, Kim JH, Han DH, Li S, Wang Y, Chang SL, Chung BI. The incidence of unsuccessful partial nephrectomy within the United States: A nationwide population-based analysis from 2003 to 2015. Urol Oncol 2017. PubMed
  • Cheung H, Wang Y, Chang SL, Khandwala Y, Del Giudice F, Chung BI. Adoption of Robot-Assisted Partial Nephrectomies: A Population-Based Analysis of U.S. Surgeons from 2004 to 2013. J. Endourol. 2017; 31:886-892. PubMed
  • Khandwala YS, Jeong IG, Han DH, Kim JH, Li S, Wang Y, Chang SL, Chung BI. Surgeon preference of surgical approach for partial nephrectomy in patients with baseline chronic kidney disease: a nationwide population-based analysis in the USA. Int Urol Nephrol 2017. PubMed
  • Leow JJ, Cole AP, Seisen T, Bellmunt J, Mossanen M, Menon M, Preston MA, Choueiri TK, Kibel AS, Chung BI, Sun M, Chang SL, Trinh QD. Variations in the Costs of Radical Cystectomy for Bladder Cancer in the USA. Eur Urol 2017. PubMed
  • Chaudhary MA, Leow JJ, Mossanen M, Chowdhury R, Jiang W, Learn PA, Weissman JS, Chang SL. Patient driven care in the management of prostate cancer: analysis of the United States military healthcare system. BMC Urol 2017; 17:56. PubMed
  • Modi PK, Farber NJ, Zavaski ME, Jang TL, Singer EA, Chang SL. Industry Payments to Urologists in 2014: an Analysis of the Open Payments Program. Urol Pract 2017; 4:342-347. PubMed
  • Khandwala YS, Jeong IG, Kim JH, Han DH, Li S, Wang Y, Chang SL, Chung BI. The Impact of Surgeon Volume on Perioperative Outcomes and Cost for Patients Receiving Robotic Partial Nephrectomy. J. Endourol. 2017. PubMed
  • Leow JJ, Weissman JS, Kimsey L, Hoburg A, Helmchen LA, Jiang W, Hevelone N, Lipsitz SR, Nguyen LL, Chang SL. Radical prostatectomy innovation and outcomes at military and civilian institutions. Am J Manag Care 2017; 23:342-347. PubMed
  • Sun M, Vetterlein M, Harshman LC, Chang SL, Choueiri TK, Trinh QD. Risk Assessment in Small Renal Masses: A Review Article. Urol Clin North Am 2017; 44:189-202. PubMed
  • Leow JJ, Leong EK, Serrell EC, Chang SL, Gruen RL, Png KS, Beaule LT, Trinh QD, Menon MM, Sammon JD. Systematic Review of the Volume-Outcome Relationship for Radical Prostatectomy. Eur Urol Focus 2017. PubMed
  • Meyer CP, Sun M, Karam JA, Leow JJ, de Velasco G, Pal SK, Chang SL, Trinh QD, Choueiri TK. Complications After Metastasectomy for Renal Cell Carcinoma-A Population-based Assessment. Eur Urol 2017. PubMed
  • Krasnow RE, Mossanen M, Koo S, Kubiak DW, Preston MA, Chung BI, Kibel AS, Chang SL. Prophylactic Antibiotics and Postoperative Complications for Radical Cystectomy: a population-based analysis in the United States. J Urol 2017. PubMed
  • Seisen T, Krasnow RE, Bellmunt J, Rouprêt M, Leow JJ, Lipsitz SR, Vetterlein MW, Preston MA, Hanna N, Kibel AS, Sun M, Choueiri TK, Trinh QD, Chang SL. Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma. J Clin Oncol 2017. PubMed
  • Hanna N, Sun M, Meyer CP, Nguyen PL, Pal SK, Chang SL, de Velasco G, Trinh QD, Choueiri TK. Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study. J Clin Oncol 2016. PubMed
  • Kurtz MP, Leow JJ, Varda BK, Logvinenko T, Yu RN, Nelson CP, Chung BI, Chang SL. Robotic versus open pediatric ureteral reimplantation: Costs and complications from a nationwide sample. J Pediatr Urol 2016. PubMed
  • Wang Y, Chen YW, Leow JJ, Levy AC, Chang SL, Gelpi FH. Cost-Effectiveness of Management Options for Small Renal Mass: A Systematic Review. Am J Clin Oncol 2016. PubMed
  • Leow JJ, Heah NH, Chang SL, Chong YL, Png KS. Outcomes After Robotic Versus Laparoscopic Partial Nephrectomy: An Updated Meta-Analysis Of 4919 Patients. J Urol 2016. PubMed
  • Cole AP, Leow JJ, Chang SL, Chung BI, Meyer CP, Kibel AS, Menon M, Nguyen PL, Choueiri TK, Reznor G, Lipsitz SR, Sammon JD, Sun M, Trinh QD. Surgeon and Hospital-Level Variation in the Costs of Robot-Assisted Radical Prostatectomy. J Urol 2016. PubMed
  • Leow JJ, Chang SL, Meyer CP, Wang Y, Hanske J, Sammon JD, Cole AP, Preston MA, Dasgupta P, Menon M, Chung BI, Trinh QD. Robot-assisted Versus Open Radical Prostatectomy: A Contemporary Analysis of an All-payer Discharge Database. Eur Urol 2016. PubMed
  • Leow JJ, Chang SL, Trinh QD. Accurately Determining Patients Who Underwent Robot-Assisted Surgery: Limitations Of Administrative Databases. BJU Int 2016. PubMed
  • Leow JJ, Chong KT, Chang SL, Bellmunt J. Upper tract urothelial carcinoma: a different disease entity in terms of management. ESMO Open 2016; 1:e000126. PubMed
  • Tinay I, Gelpi-Hammerschmidt F, Leow JJ, Allard CB, Rodriguez D, Wang Y, Chung BI, Chang SL. Trends in utilization, perioperative outcomes and costs for nephroureterectomies in the management of upper tract urothelial carcinoma (UTUC): a 10-year population-based analysis. BJU Int 2015. PubMed
  • Allard CB, Gelpi-Hammerschmidt F, Harshman LC, Choueiri TK, Faiena I, Modi P, Chung BI, Tinay I, Singer EA, Chang SL. Contemporary trends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States. Urol Oncol 2015. PubMed
  • Gelpi-Hammerschmidt F, Tinay I, Allard CB, Su LM, Preston MA, Trinh QD, Kibel AS, Wang Y, Chung BI, Chang SL. The Contemporary Incidence and Sequelae of Rhabdomyolysis Following Extirpative Renal Surgery: A Population Based Analysis. J Urol 2015. PubMed
  • Kramann R, Fleig SV, Schneider RK, Fabian SL, DiRocco DP, Maarouf O, Wongboonsin J, Ikeda Y, Heckl D, Chang SL, Rennke HG, Waikar SS, Humphreys BD. Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis. J Clin Invest 2015; 125:2935-51. PubMed
  • Chang SL, Kibel AS, Brooks JD, Chung BI. The impact of robotic surgery on the surgical management of prostate cancer in the USA. BJU Int 2015. PubMed
  • Chung BI, Leow JJ, Gelpi-Hammerschmidt F, Wang Y, Del Giudice F, De S, Chou EP, Song KH, Almario L, Chang SL. Racial Disparities in Postoperative Complications After Radical Nephrectomy: A Population-based Analysis. Urology 2015; 85:1411-6. PubMed
  • Allard CB, Meyer CP, Gandaglia G, Chang SL, Chun FK, Gelpi-Hammerschmidt F, Hanske J, Kibel AS, Preston MA, Trinh QD. The Effect of Resident Involvement on Perioperative Outcomes in Transurethral Urologic Surgeries. J Surg Educ 2015. PubMed
  • Leow JJ, Reese S, Trinh QD, Bellmunt J, Chung BI, Kibel AS, Chang SL. Impact of surgeon volume on the morbidity and costs of radical cystectomy in the USA: a contemporary population-based analysis. BJU Int 2015. PubMed
  • Lucca I, Leow JJ, Shariat SF, Chang SL. Diagnosis and management of upper tract urothelial carcinoma. Hematol Oncol Clin North Am 2015; 29:271-88, ix. PubMed
  • Leow JJ, Orsola A, Chang SL, Bellmunt J. A contemporary review of management and prognostic factors of upper tract urothelial carcinoma. Cancer Treat Rev 2015. PubMed
  • Meyer CP, Hanske J, Friedlander DF, Schmid M, Dahlem R, Trinh VQ, Chang SL, Kibel AS, Chun FK, Fisch M, Trinh QD, Eswara JR. The impact of resident involvement in male one-stage anterior urethroplasties. Urology 2015; 85:937-41. PubMed
  • Martin-Doyle W, Leow JJ, Orsola A, Chang SL, Bellmunt J. Improving selection criteria for early cystectomy in high-grade t1 bladder cancer: a meta-analysis of 15,215 patients. J Clin Oncol 2015; 33:643-50. PubMed
  • Schmid M, Ravi P, Abd-El-Barr AE, Klap J, Sammon JD, Chang SL, Menon M, Kibel AS, Fisch M, Trinh QD. Chronic kidney disease and perioperative outcomes in urological oncological surgery. Int J Urol 2014. PubMed
  • Leow JJ, Gandaglia G, Sood A, Ruhotina N, Klett DE, Sammon JD, Schmid M, Sun M, Chang SL, Kibel AS, Trinh QD. Readmissions after major urologic cancer surgery. Can J Urol 2014; 21:7537-46. PubMed
  • Schmid M, Abd-El-Barr AE, Gandaglia G, Sood A, Olugbade K, Ruhotina N, Sammon JD, Varda B, Chang SL, Kibel AS, Chun FK, Menon M, Fisch M, Trinh QD. Predictors of 30-day acute kidney injury following radical and partial nephrectomy for renal cell carcinoma. Urol Oncol 2014. PubMed
  • Ravi P, Karakiewicz PI, Roghmann F, Gandaglia G, Choueiri TK, Menon M, McKay RR, Nguyen PL, Sammon JD, Sukumar S, Varda B, Chang SL, Kibel AS, Sun M, Trinh QD. Mental health outcomes in elderly men with prostate cancer. Urol Oncol 2014. PubMed
  • Gandaglia G, Varda B, Sood A, Pucheril D, Konijeti R, Sammon JD, Sukumar S, Menon M, Sun M, Chang SL, Montorsi F, Kibel AS, Trinh QD. Short-term perioperative outcomes of patients treated with radical cystectomy for bladder cancer included in the National Surgical Quality Improvement Program (NSQIP) database. Can Urol Assoc J 2014; 8:E681-7. PubMed
  • Ruhotina N, Dagenais J, Gandaglia G, Sood A, Abdollah F, Chang SL, Leow JJ, Olugbade K, Rai A, Sammon JD, Schmid M, Varda B, Zorn KC, Menon M, Kibel AS, Trinh QD. The impact of resident involvement in minimally-invasive urologic oncology procedures. Can Urol Assoc J 2014; 8:334-40. PubMed
  • Leow JJ, Reese SW, Jiang W, Lipsitz SR, Bellmunt J, Trinh QD, Chung BI, Kibel AS, Chang SL. Propensity-matched comparison of morbidity and costs of open and robot-assisted radical cystectomies: a contemporary population-based analysis in the United States. Eur Urol 2014. PubMed
  • Leow JJ, Martin-Doyle W, Fay AP, Choueiri TK, Chang SL, Bellmunt J. A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma. Eur Urol 2014. PubMed
  • Leow JJ, Martin-Doyle W, Rajagopal PS, Patel CG, Anderson EM, Rothman AT, Cote RJ, Urun Y, Chang SL, Choueiri TK, Bellmunt J. Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials. Eur Urol 2014. PubMed
  • Bhojani N, Gandaglia G, Sood A, Rai A, Pucheril D, Chang SL, Karakiewicz PI, Menon M, Olugbade K, Ruhotina N, Sammon JD, Sukumar S, Sun M, Ghani KR, Schmid M, Varda B, Kibel AS, Zorn KC, Trinh QD. Morbidity and mortality after benign prostatic hyperplasia surgery: data from the American College of Surgeons national surgical quality improvement program. J Endourol 2014. PubMed
  • Shinagare AB, Silverman SG, Gershanik EF, Chang SL, Khorasani R. Evaluating hematuria: impact of guideline adherence on urologic cancer diagnosis. Am J Med 2014. PubMed
  • Antczak C, Trinh VQ, Sood A, Ravi P, Roghmann F, Trudeau V, Chang SL, Karakiewicz PI, Kibel AS, Krishna N, Nguyen PL, Saad F, Sammon JD, Sukumar S, Zorn KC, Sun M, Trinh QD. The health care burden of skeletal related events in patients with renal cell carcinoma and bone metastasis. J Urol 2014. PubMed
  • Gandaglia G, Sammon JD, Chang SL, Choueiri TK, Hu JC, Karakiewicz PI, Kibel AS, Kim SP, Konijeti R, Montorsi F, Nguyen PL, Sukumar S, Menon M, Sun M, Trinh QD. Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era. J Clin Oncol 2014. PubMed
  • Look Hong NJ, Chang SL, Raut CP. The economic impact of cytoreductive surgery and tyrosine kinase inhibitor therapy in the treatment of advanced gastrointestinal stromal tumours: a Markov chain decision analysis. Eur J Cancer 2014; 50:397-405. PubMed
  • Chang SL, Cipriano LE, Harshman LC, Garber AM, Chung BI. Cost-effectiveness analysis of nephron sparing options for the management of small renal masses. J Urol 2011; 185:1591-7. PubMed
  • Hsu M, Chang SL, Ferrari M, Nolley R, Presti JC, Brooks JD. Length of site-specific positive surgical margins as a risk factor for biochemical recurrence following radical prostatectomy. Int J Urol 2011. PubMed
  • Chang SL, Harshman LC, Presti JC. Impact of common medications on serum total prostate-specific antigen levels: analysis of the National Health and Nutrition Examination Survey. J Clin Oncol 2010; 28:3951-7. PubMed
  • Levesque BG, Cipriano LE, Chang SL, Lee KK, Owens DK, Garber AM. Cost effectiveness of alternative imaging strategies for the diagnosis of small-bowel Crohn's disease. Clin Gastroenterol Hepatol 2010; 8:261-7, 267.e1-4. PubMed
  • Chang SL, Freedland SJ, Terris MK, Aronson WJ, Kane CJ, Amling CL, Presti JC. Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH database. Urology 2010; 75:439-44. PubMed
  • Chang SL, Gonzalgo ML. Editorial comment. J Urol 2010; 183:459; discussion 459. PubMed
  • Chang SL, Liao JC, Shinghal R. Decreasing use of luteinizing hormone-releasing hormone agonists in the United States is Independent of Reimbursement Changes: A Medicare and Veterans Health Administration claims analysis. J Urol 2009; 182:255-60; discussion 261. PubMed
  • Chang SL, Gonzalgo ML. Surgery: laparoscopic prostatectomy: learning curve and cancer control. Nat Rev Urol 2009; 6:361-2. PubMed
Hide
Visualize Collaborations
Learn how these members are similar
Similar Members

DF/HCC members that share similar concepts* with Steven L. Chang, MD but have yet to coauthor a publication with this researcher.

* Concepts are MeSH terms, automatically derived from member publications

Similar Members